DVS-233

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

FibromyalgiaMenopause

Phase 2

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

TerminatedNCT00301431

Wyeth is now a wholly owned subsidiary of PfizerFibromyalgia

Start: 2006-08-31End: 2007-06-30Target: 1050Updated: 2007-12-05

Phase 3

Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause

CompletedNCT00195546

Wyeth is now a wholly owned subsidiary of PfizerMenopause

Start: 2005-04-30End: 2006-01-31Target: 465Updated: 2007-06-01